RICHARDSON, Texas, June 16 /PRNewswire/ -- Zyvex Corporation today announced that Hon. Jonathan C. Javitt, M.D., M.P.H. has joined its Scientific Advisory Board. Dr. Javitt is a Senior Fellow of the Potomac Institute for Policy Studies and an adjunct Professor of the Johns Hopkins University School of Medicine. In May 2003, Dr. Javitt was appointed by President George W. Bush to the President's Information Technology Advisory Committee, where he chairs the subcommittee on health information technology. "Jonathan Javitt has earned a world-wide reputation in the Health Care industry," said James Von Ehr, Zyvex Founder and CEO. "Adding him to our Scientific Advisory Board further reflects our commitment to nanotechnology commercialization. He adds unique professional competencies and exceptional business experience." Javitt is also Vice-Chairman of Health Directions, LLC a Bethesda-based investment group that focuses on developing computer solutions to improve the delivery of Health Care. He is Chief Scientific Officer of Active Health Management, Inc. "Dr. Javitt is regularly consulted on national policy and legal issues and has been admitted as an expert consultant in both Federal and State jurisdictions," said Zyvex President, Dr. Thomas A. Cellucci. "We are very pleased that he has joined our team." Javitt was appointed to the faculty of Johns Hopkins University in 1988 and was the first ophthalmologist to be granted a Physician Scientist Award by the National Eye Institute of the National Institutes of Health. He joined the faculty of Georgetown University in 1990. He is also the author of more than 200 publications related to Health Care delivery and holds two U.S. patents. His work has been published in the New England Journal of Medicine, the Journal of the American Medical Association, as well as numerous other peer-reviewed publications. In 1984, Javitt authored "Computers in Medicine: Applications and Possibilities," one of the earliest books in the field. Since that time, he has been involved in the development and commercialization of a variety of Health Care computer applications, including electronic medical record systems, epidemiologic tracking systems and, most recently, sentinel systems for detecting medical errors. Javitt has served as a member of the White House Health Reform Task Force. He has been an expert consultant to the World Bank, the National Institutes of Health, the Health Care Financing Administration, the Department of Veterans Affairs, and the ministries of health of United Kingdom, Sweden, Australia, Japan, and the Netherlands. He has been active as a consultant in pharmacoeconomics and pharmaceutical development and has completed product development projects for Alcon, Allergan, American Home Products, Chiron, Lilly, Merck, Pfizer, and Pharmacia. Javitt has been honored as a visiting professor by the University of New South Wales (Sydney, Australia), the University of Melbourne (Melbourne, Australia), Yamanashi Medical College (Kofu, Japan), and numerous institutions in the United States. He is listed in "Who's Who in the World" and has been elected to membership in the Cosmos Club (Washington, DC). Javitt graduated in 1978 with honors in Biochemistry from Princeton University and earned his M.D. at Cornell University Medical College. He was awarded a Kellogg Foundation Fellowship to attend the Harvard School of Public Health, from which he graduated with an M.P.H. in Health Policy and Management. Other Zyvex Scientific Advisory Board members include Dr. Alan MacDiarmid, a 2000 Nobel Laureate in Chemistry, a Member of the National Academy of Science, and a member of the National Academy of Engineering; Dr. Nicholas J. Colella, Tessera Technologies; Dr. Wilson Ho, University of California (Irvine); Dr. Joseph W. Lyding, University of Illinois; Dr. Kristofer S. J. Pister, University of California (Berkeley); Dr. Rodney S. Ruoff, Northwestern University; Dr. Paul S. Weiss, Pennsylvania State University; Dr. Peter Will, University of Southern California. Zyvex's Scientific Advisory Board contributes to Zyvex's vision of providing flexible, automated manufacturing at ever decreasing size scales. About the Company Zyvex Corporation, based in Richardson, Texas, is the first molecular nanotechnology company. Zyvex's vision is to be the leading worldwide supplier of tools, products, and services that enable adaptable, affordable, and molecularly precise manufacturing. Zyvex commercializes nanotechnology to address real-world applications with high-growth potential. Zyvex carries its scientific breakthroughs into key commercial applications in the area of materials, tools, and structures. Contact Information Zyvex Corporation is at http://www.zyvex.com . Contact Katharine Green, Director of Corporate Communications, at firstname.lastname@example.org or by phone at 972.235.7881 (ext. 220).
SOURCE Zyvex Corporation